Genome-wide binding of the CRISPR endonuclease Cas9 in mammalian cells

Cited by (944)

Items 301–400 of 944

  1. Advances in detecting and reducing off-target effects generated by CRISPR-mediated genome editing
    Jinjing Li, Shunyan Hong, Wan‐Jin Chen, Erwei Zuo, Hui Yang · 2019 · Journal of genetics and genomics/Journal of Genetics and Genomics
  2. Error-corrected next generation sequencing – Promises and challenges for genotoxicity and cancer risk assessment
    Francesco Marchetti, Renato Cardoso, Connie L. Chen, George R. Douglas, Joanne M. Elloway, Patricia A. Escobar, Tod A. Harper, Robert H. Heflich, Darren Kidd, Anthony M. Lynch et al. · 2023 · Mutation Research/Reviews in Mutation Research
  3. CRISPR–Cas9-mediated genome editing and guide RNA design
    Michael V. Wiles, Wenning Qin, Albert W. Cheng, Haoyi Wang · 2015 · Mammalian Genome
  4. dCas9-mediated Nanoelectrokinetic Direct Detection of Target Gene for Liquid Biopsy
    Hyomin Lee, Jihye Choi, Euihwan Jeong, Seongho Baek, Hee Chan Kim, Jong‐Hee Chae, Youngil Koh, Sang Woo Seo, Jin‐Soo Kim, Sung Jae Kim · 2018 · Nano Letters
  5. Reversible Disruption of Specific Transcription Factor-DNA Interactions Using CRISPR/Cas9
    S. Ali Shariati, Antonia A. Dominguez, Shicong Xie, Marius Wernig, Lei S. Qi, Jan Marcel Skotheim · 2019 · Molecular Cell
  6. Gene Editing and Genotoxicity: Targeting the Off-Targets
    Georges Blattner, Alessia Cavazza, Adrian James Thrasher, Giandomenico Turchiano · 2020 · Frontiers in Genome Editing
  7. Selective TnsC recruitment enhances the fidelity of RNA-guided transposition
    Florian T. Hoffmann, Minjoo Kim, Leslie Y. Beh, Jing Wang, Phuc Leo H. Vo, Diego R. Gelsinger, Jerrin Thomas George, Christopher Acree, Jason T. Mohabir, Israel S. Fernández et al. · 2022 · Nature
  8. Unraveling the mechanisms of PAMless DNA interrogation by SpRY-Cas9
    Grace N. Hibshman, Jack P. K. Bravo, Matthew M. Hooper, Tyler L. Dangerfield, Hongshan Zhang, Ilya J. Finkelstein, Kenneth Allen Johnson, David Ward Taylor · 2024 · Nature Communications
  9. Tracking and transforming neocortical progenitors by CRISPR/Cas9 gene targeting and PiggyBac transposase lineage labeling
    Fuyi Chen, Joel A. Rosiene, Alicia Che, Albert J. Becker, Joseph J. LoTurco · 2015 · Development
  10. Genome Editing with CRISPR-Cas9: Can It Get Any Better?
    Maximilian Haeussler, Jean‐Paul Concordet · 2016 · Journal of genetics and genomics/Journal of Genetics and Genomics
  11. T7 Polymerase Expression of Guide RNAs in vivo Allows Exportable CRISPR-Cas9 Editing in Multiple Yeast Hosts
    Nicholas J. Morse, James M. Wagner, Kevin B. Reed, Madan R. Gopal, Lars H. Lauffer, Hal S. Alper · 2018 · ACS Synthetic Biology
  12. Transposon-encoded nucleases use guide RNAs to promote their selfish spread
    Meers, Chance, Le, Hoang C., Pesari, Sanjana R., Hoffmann, Florian T., Walker, Matt W. G., Gezelle, Jeanine, Tang, Stephen, Sternberg, Samuel H. · 2023 · Nature
  13. A screening method to identify efficient sgRNAs in Arabidopsis, used in conjunction with cell-specific lignin reduction
    Yan Liang, Aymerick Eudes, Sasha Yogiswara, Beibei Jing, Veronica Teixeira Benites, Reo Yamanaka, Clarabelle Cheng-Yue, Edward E. K. Baidoo, Jenny C. Mortimer, Henrik Vibe Scheller et al. · 2019 · Biotechnology for Biofuels
  14. Optimizing Systems for Cas9 Expression in Toxoplasma gondii
    Benedikt M. Markus, George W. Bell, Hernán Lorenzi, Sebastian Lourido · 2019 · mSphere
  15. CRISPR system: Discovery, development and off-target detection
    Chen, Shengmiao, Yao, Yufeng, Zhang, Yanchun, Fan, Gaofeng · 2020 · Cellular Signalling
  16. Quantification of Cas9 binding and cleavage across diverse guide sequences maps landscapes of target engagement
    Evan A. Boyle, Winston R. Becker, Hua Bai, Janice S. Chen, Jennifer A. Doudna, William James Greenleaf · 2021 · Science Advances
  17. Muscle growth in targeted knockout common carp (Cyprinus carpio) mstn gene with low off-target effects
    Neetu Shahi, Sumanta Kumar Mallik, Debajit Sarma · 2021 · Aquaculture
  18. CRISPR-Cas9 for medical genetic screens: applications and future perspectives
    Hui-Ying Xue, Li-Juan Ji, Ai-Mei Gao, Ping Liu, Jing-Dong He, Xiaojie Lu · 2015 · Journal of Medical Genetics
  19. Impact of CRISPR-Cas9-Based Genome Engineering in Farm Animals
    Parul Singh, Syed Azmal Ali · 2021 · Veterinary Sciences
  20. Chemical Biology Approaches to Genome Editing: Understanding, Controlling, and Delivering Programmable Nucleases
    Johnny H. Hu, Kevin M Davis, David R. Liu · 2016 · Cell chemical biology
  21. Efficient genome editing in hematopoietic stem cells with helper-dependent Ad5/35 vectors expressing site-specific endonucleases under microRNA regulation
    Kamola Saydaminova, Xun Ye, Hongjie Wang, Maximilian Richter, Martin Ho, Hongzhuan Chen, Ning Xu, Jin‐Soo Kim, Eirini P. Papapetrou, Michael C. Holmes et al. · 2015 · Molecular Therapy — Methods & Clinical Development
  22. A CRISPR Path to Engineering New Genetic Mouse Models for Cardiovascular Research
    Joseph M. Miano, Qiuyu Martin Zhu, Charles J. Lowenstein · 2016 · Arteriosclerosis Thrombosis and Vascular Biology
  23. Determination of local chromatin interactions using a combined CRISPR and peroxidase APEX2 system
    Wenqing Qiu, Zhijiao Xu, Min Zhang, Dandan Zhang, Hui Fan, Taotao Li, Qianfeng Wang, Peiru Liu, Zaihua Zhu, Duo Du et al. · 2019 · Nucleic Acids Research
  24. Site-Specific and Enzymatic Cross-Linking of sgRNA Enables Wavelength-Selectable Photoactivated Control of CRISPR Gene Editing
    Dongyang Zhang, Luping Liu, Shuaijiang Jin, Ember M. Tota, Zijie Li, Xijun Piao, Xuan Zhang, Xiang‐Dong Fu, Neal K. Devaraj · 2022 · Journal of the American Chemical Society
  25. CRISPR/Cas9: From Genome Engineering to Cancer Drug Discovery
    Ji Luo · 2016 · Trends in cancer
  26. Design principles for nuclease-deficient CRISPR-based transcriptional regulators
    Michael Krogh Jensen · 2018 · FEMS Yeast Research
  27. Synthesis of an arrayed sgRNA library targeting the human genome
    Tobias Schmidt, Jonathan Leo Schmid-Burgk, Veit Hornung · 2015 · Scientific Reports
  28. PAM multiplicity marks genomic target sites as inhibitory to CRISPR-Cas9 editing
    Abba Malina, Christopher J. F. Cameron, Francis Robert, Mathieu Blanchette, Josée Dostie, Jerry Pelletier · 2015 · Nature Communications
  29. Cell Reprogramming With CRISPR/Cas9 Based Transcriptional Regulation Systems
    К. М. Шакирова, Viktoriia Y. Ovchinnikova, Erdem Bairovich Dashinimaev · 2020 · Frontiers in Bioengineering and Biotechnology
  30. Cloning-free CRISPR
    Mandana Arbab, Sharanya Srinivasan, Tatsunori Hashimoto, Niels Geijsen, Richard I. Sherwood · 2015 · Stem Cell Reports
  31. Effects of CRISPR/Cas9 dosage on TICAM1 and RBL gene mutation rate, embryonic development, hatchability and fry survival in channel catfish
    Ahmed Elaswad, Karim M. Khalil, Zhi Ye, Zhanjiang Liu, Shikai Liu, Eric Peatman, Ramjie Odin, Khoi Minh Vo, David Drescher, Kamal Gosh et al. · 2018 · Scientific Reports
  32. Chemical engineering of CRISPR–Cas systems for therapeutic application
    Halle M. Barber, Adrian A. Pater, Keith T. Gagnon, Masad José Damha, Daniel O’Reilly · 2024 · Nature Reviews Drug Discovery
  33. Cutting Edge Genetics: CRISPR/Cas9 Editing of Plant Genomes
    Cara L. Soyars, Brenda A. Peterson, Christian A. Burr, Zachary L. Nimchuk · 2018 · Plant and Cell Physiology
  34. Systems Metabolic Engineering of Escherichia coli
    Kyeong Rok Choi, Jae Ho Shin, Jae Sung Cho, Dongsoo Yang, Sang Yup Lee · 2016 · EcoSal Plus
  35. Targeting cancer epigenetics with CRISPR-dCAS9: Principles and prospects
    Mohammad Mijanur Rahman, Trygve O. Tollefsbol · 2020 · Methods
  36. Human sensory neurons derived from pluripotent stem cells for disease modelling and personalized medicine
    Angelika Lampert, David Bennett, Lucy McDermott, Anika Neureiter, Esther Eberhardt, Beate Winner, Martin Zenke · 2020 · Neurobiology of Pain
  37. Genome edited wheat- current advances for the second green revolution
    Muhammad Jawad Akbar Awan, Komal Pervaiz, Awais Rasheed, Imran Ul Amin, Nasir Ahmad Saeed, Kanwarpal S. Dhugga, Shahid Mansoor · 2022 · Biotechnology Advances
  38. CRISPR-Cas9: a promising genetic engineering approach in cancer research
    Zubair Ahmed Ratan, Young–Jin Son, Mohammad Faisal Haidere, Bhuiyan Mohammad Mahtab Uddin, Md Abdullah Yusuf, Sojib Bin Zaman, Jong‐Hoon Kim, Laila Anjuman Banu, Jae Youl Cho · 2018 · Therapeutic Advances in Medical Oncology
  39. Sequence specificity in DNA binding is mainly governed by association
    Emil Marklund, Guanzhong Mao, Jinwen Yuan, Spartak Zikrin, Eldar Abdurakhmanov, Sebastian Deindl, Johan Elf · 2022 · Science
  40. Extracellular vesicles associated microRNAs: Their biology and clinical significance as biomarkers in gastrointestinal cancers
    Yuan Li, Silei Sui, Ajay Goel · 2024 · Seminars in Cancer Biology
  41. Chimeric Guides Probe and Enhance Cas9 Biochemical Activity
    Zachary J. Kartje, Christopher L. Barkau, Kushal J. Rohilla, Eman A. Ageely, Keith T. Gagnon · 2018 · Biochemistry
  42. The Chromatin Structure of CRISPR-Cas9 Target DNA Controls the Balance between Mutagenic and Homology-Directed Gene-Editing Events
    Josephine M. Janssen, Xiaoyu Chen, Jin Liu, Manuel A.F.V. Gonçalves · 2019 · Molecular Therapy — Nucleic Acids
  43. Impact of CRISPR interference on strain development in biotechnology
    Kerstin Schultenkämper, Luciana Fernandes Brito, Volker F. Wendisch · 2020 · Biotechnology and Applied Biochemistry
  44. The Power of CRISPR-Cas9-Induced Genome Editing to Speed Up Plant Breeding
    Hieu X. Cao, Wenqin Wang, Lê Thị Thu Hiền, Giang T. H. Vu · 2016 · International Journal of Genomics
  45. CRISPR therapeutic tools for complex genetic disorders and cancer (Review)
    Stella Baliou, Maria Adamaki, Anthony M. Kyriakopoulos, Demetrios A. Spandidos, Mihalis I. Panayiotidis, Ioannis Christodoulou, Vassilis C. Zoumpourlis · 2018 · International Journal of Oncology
  46. Deciphering essential cistromes using genome-wide CRISPR screens
    Teng Fei, Wei Li, Jingyu Peng, Tengfei Xiao, Chen-Hao Chen, Alexander Wu, Jialiang Huang, Chongzhi Zang, X. Shirley Liu, Myles A Brown · 2019 · Proceedings of the National Academy of Sciences
  47. Genome editing enables reverse genetics of multicellular development in the choanoflagellate Salpingoeca rosetta
    David Scott Booth, Nicole King · 2020 · eLife
  48. Inhibition of CRISPR-Cas12a DNA targeting by nucleosomes and chromatin
    Isabel Strohkendl, Fatema A. Saifuddin, Bryan A. Gibson, Michael K. Rosen, Rick Russell, Ilya J. Finkelstein · 2021 · Science Advances
  49. Induction of site-specific chromosomal translocations in embryonic stem cells by CRISPR/Cas9
    Junfeng Jiang, Li Zhang, Xingliang Zhou, Xi Chen, Guanyi Huang, Fengsheng Li, Ruizhe Wang, Nancy L. Wu, Youzhen Yan, Chang Tong et al. · 2016 · Scientific Reports
  50. Rapid Generation of Human Genetic Loss-of-Function iPSC Lines by Simultaneous Reprogramming and Gene Editing
    Andrew M. Tidball, Louis T. Dang, Trevor W. Glenn, Emma G. Kilbane, Daniel Klarr, Joshua L. Margolis, Michael D. Uhler, Jack M. Parent · 2017 · Stem Cell Reports
  51. Insights into maize genome editing via CRISPR/Cas9
    Astha Agarwal, Pranjal Yadava, Krishan Kumar, Ishwar Singh, Tanushri Kaul, A. Pattanayak, Pawan Kumar Agrawal · 2018 · Physiology and Molecular Biology of Plants
  52. SARS-CoV-2 in wastewater: From detection to evaluation
    Danwei Zhang, Solco S. Faye Duran, Wei Yang Lim, Chee Kiang Ivan Tan, Wun Chet Davy Cheong, Ady Suwardi, Xian Jun Loh · 2022 · Materials Today Advances
  53. Massively parallel genomic perturbations with multi-target CRISPR interrogates Cas9 activity and DNA repair at endogenous sites
    Roger S. Zou, Alberto Marín-González, Yang Liu, Hans B. Liu, Leo L. Shen, Rachel K. Dveirin, Jay X. J. Luo, Reza Kalhor, Taekjip Ha · 2022 · Nature Cell Biology
  54. Benchmarking deep learning methods for predicting CRISPR/Cas9 sgRNA on- and off-target activities
    Zhang, Guishan, Luo, Ye, Dai, Xianhua, Dai, Zhiming · 2023 · Briefings in Bioinformatics
  55. Extracellular Vesicles in Therapeutics: A Comprehensive Review on Applications, Challenges, and Clinical Progress
    Jiyoung Goo, Yeji Lee, Jeongmin Lee, In‐San Kim, Cherlhyun Jeong · 2024 · Pharmaceutics
  56. Genome engineering in ophthalmology: Application of CRISPR/Cas to the treatment of eye disease
    Sandy S. C. Hung, Tristan McCaughey, Olivia G. Swann, Alice Pébay, Alex William Hewitt · 2016 · Progress in Retinal and Eye Research
  57. Baculoviral delivery of CRISPR/Cas9 facilitates efficient genome editing in human cells
    Sanne Hindriksen, Arne J. Bramer, My Anh Truong, Martijn J.M. Vromans, Jasmin B. Post, Ingrid Verlaan-Klink, Hugo J.G. Snippert, Susanne M. A. Lens, Michael A. Hadders · 2017 · PLoS ONE
  58. Highly efficient gene inactivation by adenoviral CRISPR/Cas9 in human primary cells
    Voets, Olaf, Tielen, Frans, Elstak, Edo, Benschop, Julian, Grimbergen, Max, Stallen, Jan, Janssen, Richard, van Marle, Andre, Essrich, Christian · 2017 · PLOS ONE
  59. CRISPR/Cas9 System: A Bacterial Tailor for Genomic Engineering
    Bilal Ahmad Lone, Shibendra Kumar Lal Karna, Faiz Ahmad, Nerina Shahi, Yuba Raj Pokharel · 2018 · Genetics Research International
  60. Engineering synthetic TALE and CRISPR/Cas9 transcription factors for regulating gene expression
    Ami M. Kabadi, Charles A. Gersbach · 2014 · Methods
  61. The CRISPR/Cas9 system targeting EGFR exon 17 abrogates NF-κB activation via epigenetic modulation of UBXN1 in EGFRwt/vIII glioma cells
    Kai Huang, Chao Yang, Qixue Wang, Yan-sheng Li, Chuan Fang, Yanli Tan, Jian-wei Wei, Yunfei Wang, Xin Li, Junhu Zhou et al. · 2016 · Cancer Letters
  62. Detecting and typing target DNA with a novel CRISPR-typing PCR (ctPCR) technique
    Beibei Zhang, Qiang Xia, Qiao Wang, Xinyi Xia, Jinke Wang · 2018 · Analytical Biochemistry
  63. CRISPR/Cas9-Based Lateral Flow and Fluorescence Diagnostics
    Mark J. Osborn, Akshay Bhardwaj, Samuel P. Bingea, Friederike Knipping, Colby J. Feser, Christopher J. Lees, Daniel P. Collins, Clifford J. Steer, Bruce R. Blazar, Jakub Tolar · 2021 · Bioengineering
  64. Recent advancements in CRISPR/Cas technology for accelerated crop improvement
    Debajit Das, Dhanawantari L. Singha, Ricky Raj Paswan, Naimisha Chowdhury, Monica Sharma, Palakolanu Sudhakar Reddy, Channakeshavaiah Chikkaputtaiah · 2022 · Planta
  65. A modular open platform for systematic functional studies under physiological conditions
    Christopher B. Mulholland, Martha Smets, Elisabeth Schmidtmann, Susanne Leidescher, Yolanda Markaki, Mario Hofweber, Weihua Qin, Massimiliano Manzo, Elisabeth Kremmer, Katharina Thanisch et al. · 2015 · Nucleic Acids Research
  66. Conformational regulation of CRISPR-associated nucleases
    Ryan N. Jackson, Paul B. G. van Erp, Samuel H. Sternberg, Blake Wiedenheft · 2017 · Current Opinion in Microbiology
  67. The Chromatin Structure Differentially Impacts High-Specificity CRISPR-Cas9 Nuclease Strategies
    Xiaoyu Chen, Jin Liu, Josephine M. Janssen, Manuel A.F.V. Gonçalves · 2017 · Molecular Therapy — Nucleic Acids
  68. A benchmark of computational CRISPR-Cas9 guide design methods
    Jacob Bradford, Dimitri Perrin · 2019 · PLoS Computational Biology
  69. Technologies and Computational Analysis Strategies for CRISPR Applications
    Kendell Clement, Jonathan Y. Hsu, Matthew C. Canver, J. Keith Joung, Luca Pinello · 2020 · Molecular Cell
  70. PAM-flexible Engineered FnCas9 variants for robust and ultra-precise genome editing and diagnostics
    Sundaram Acharya, Asgar Hussain Ansari, Prosad Kumar Das, Seiichi Hirano, Meghali Aich, Riya Rauthan, Sudipta Mahato, Savitri Maddileti, Sajal Sarkar, Manoj Kumar et al. · 2024 · Nature Communications
  71. CRISPR‐driven diagnostics: Molecular mechanisms, clinical efficacy and translational challenges
    Zilong Wang, Qianqian Wang, Jiaming Zhang, Bingyu Li, Yuke Li, Zhengbo Chen, Dandan Guo, Shuying Feng · 2025 · Clinical and Translational Medicine
  72. Single Molecule Localization and Discrimination of DNA–Protein Complexes by Controlled Translocation Through Nanocapillaries
    Roman D. Bulushev, Sanjin Marion, Ekaterina Petrova, Sebastian J. Davis, Sebastian J. Maerkl, Aleksandra Rađenović · 2016 · Nano Letters
  73. Arrayed mutant haploid embryonic stem cell libraries facilitate phenotype-driven genetic screens
    Guang Liu, Xue Lian Wang, Yufang Liu, Meili Zhang, Tao Cai, Zhirong Shen, Yuyan Jia, Yue Huang · 2017 · Nucleic Acids Research
  74. Tuning CRISPR-Cas9 Gene Drives in Saccharomyces cerevisiae
    Emily Roggenkamp, Rachael M. Giersch, Madison N. Schrock, Emily Turnquist, Megan Halloran, Gregory C. Finnigan · 2018 · G3 Genes Genomes Genetics
  75. Enhanced Genome Editing with Cas9 Ribonucleoprotein in Diverse Cells and Organisms
    Behnom Farboud, Erin Jarvis, Theodore L. Roth, Jiyung J. Shin, Jacob E. Corn, Alexander Marson, Barbara J Meyer, Nipam H. Patel, Megan L. Hochstrasser · 2018 · Journal of Visualized Experiments
  76. Cas9 ribonucleoprotein complex allows direct and rapid analysis of coding and noncoding regions of target genes in Pleurodeles waltl development and regeneration
    Miyuki Suzuki, Toshinori Hayashi, Takeshi Inoue, Kiyokazu Agata, Miki Hirayama, Miyuzu Suzuki, Shuji Shigenobu, Takashi Takeuchi, Takashi Yamamoto, Kenichi Suzuki · 2018 · Developmental Biology
  77. A piggyBac-based toolkit for inducible genome editing in mammalian cells
    Megan D. Schertzer, Eliza Thulson, K. C. Braceros, David M. Lee, Emma R. Hinkle, Ryan M. Murphy, Susan O. Kim, E. Vitucci, J. M. Calabrese · 2018 · bioRxiv
  78. Targeted mutagenesis with sequence‐specific nucleases for accelerated improvement of polyploid crops: Progress, challenges, and prospects
    David May, Katalin Paldi, Fredy Altpeter · 2023 · The Plant Genome
  79. CRISPR-Cas System: The Current and Emerging Translational Landscape
    Narendranath Bhokisham, Ethan Laudermilch, Lindsay L. Traeger, Tonya D. Bonilla, Mercedes Ruíz-Estévez, Jordan R. Becker · 2023 · Cells
  80. The Current State of Naïve Human Pluripotency
    Benjamin T. Dodsworth, Rowan Flynn, Sally A. Cowley · 2015 · Stem Cells
  81. CRISPR-Based Genome Editing: Advancements and Opportunities for Rice Improvement
    Workie Anley Zegeye, Mesfin Tsegaw, Yingxin Zhang, Liyong Cao · 2022 · International Journal of Molecular Sciences
  82. Personalised genome editing – The future for corneal dystrophies
    Tara Moore, Kathleen A. Christie, John Marshall, M. Andrew Nesbit · 2018 · Progress in Retinal and Eye Research
  83. Herpesviral lytic gene functions render the viral genome susceptible to novel editing by CRISPR/Cas9
    Hyung Suk Oh, Werner Neuhausser, Pierce Eggan, Magdalena Angelova, Rory D. Kirchner, Kevin C. Eggan, David M. Knipe · 2019 · eLife
  84. Systematic in vitro profiling of off-target affinity, cleavage and efficiency for CRISPR enzymes
    Liyang Zhang, H. Tomas Rube, Christopher A. Vakulskas, Mark A. Behlke, Harmen J. Bussemaker, Miles A. Pufall · 2020 · Nucleic Acids Research
  85. Minimizing off-Target Mutagenesis Risks Caused by Programmable Nucleases
    Kentaro Ishida, Peter Gee, Akitsu Hotta · 2015 · International Journal of Molecular Sciences
  86. Keeping CRISPR/Cas on-Target
    Muhammad Jamal, Faheem Ahmed Khan, Da Lin, Zeshan Habib, Jinxia Dai, Gang Cao · 2016 · Current Issues in Molecular Biology
  87. GUIDEseq: a bioconductor package to analyze GUIDE-Seq datasets for CRISPR-Cas nucleases
    Lihua Julie Zhu, Michael Lawrence, Ankit Gupta, Hervé Pagès, Alper Küçükural, Manuel G. Garber, Scot A. Wolfe · 2017 · BMC Genomics
  88. Targeting DNA methyltransferases in non-small-cell lung cancer
    Minnatallah Al-Yozbaki, Ibtissam Jabre, Naeem Hasan Syed, Cornelia M. Wilson · 2021 · Seminars in Cancer Biology
  89. The AAV-mediated and RNA-guided CRISPR/Cas9 system for gene therapy of DMD and BMD
    Wang, Jing-Zhang, Wu, Peng, Shi, Zhi-Min, Xu, Yan-Li, Liu, Zhi-Jun · 2017 · Brain and Development
  90. Novel Genome-Editing Tools to Model and Correct Primary Immunodeficiencies
    Lisa M. Ott de Bruin, Stefano Volpi, Kiran Musunuru · 2015 · Frontiers in Immunology
  91. Optimization of Cas9 activity through the addition of cytosine extensions to single-guide RNAs
    Masaki Kawamata, Hiroshi I. Suzuki, Ryota Kimura, Atsushi Suzuki · 2023 · Nature Biomedical Engineering
  92. CRISPR‐Cas: From the Bacterial Adaptive Immune System to a Versatile Tool for Genome Engineering
    Marion Kirchner, Sabine Schneider · 2015 · Angewandte Chemie International Edition
  93. CRISPR‐Cas9 systems: versatile cancer modelling platforms and promising therapeutic strategies
    Wanshun Wen, Zhi‐Min Yuan, Shijie Ma, Xu Jiang, Dongtang Yuan · 2015 · International Journal of Cancer
  94. CRISPR-Cas9: from Genome Editing to Cancer Research
    Si Chen, Heng Sun, Kai Miao, Chu‐Xia Deng · 2016 · International Journal of Biological Sciences
  95. R-loop formation by dCas9 is mutagenic in Saccharomyces cerevisiae
    Marian F. Laughery, Hannah C Mayes, Ivan K Pedroza, John J. Wyrick · 2018 · Nucleic Acids Research
  96. A kinetic model predicts SpCas9 activity, improves off-target classification, and reveals the physical basis of targeting fidelity
    Behrouz Eslami-Mossallam, Misha Klein, Constantijn P. van der Smagt, Koen van der Sanden, Stephen K. Jones, John A. Hawkins, Ilya J. Finkelstein, Martin Depken · 2022 · Nature Communications
  97. Paving the way towards precise and safe CRISPR genome editing
    Paweł Śledziński, Magdalena Dabrowska, Mateusz Nowaczyk, Marta Olejniczak · 2021 · Biotechnology Advances
  98. Advances in targeting cancer epigenetics using CRISPR-dCas9 technology: A comprehensive review and future prospects
    Jeevitha Rajanathadurai, Elumalai Perumal, Jospin Sindya · 2024 · Functional & Integrative Genomics
  99. A Toolkit of CRISPR-Based Genome Editing Systems in Drosophila
    Xu Jiang, Xingjie Ren, Jin Sun, Xia Wang, Huanhuan Qiao, Bowen Xu, Luping Liu, Jian‐Quan Ni · 2015 · Journal of genetics and genomics/Journal of Genetics and Genomics
  100. Knockout of MARCH2 inhibits the growth of HCT116 colon cancer cells by inducing endoplasmic reticulum stress
    Dan Xia, Wanli Ji, Chentong Xu, Xin Lin, Xiaokun Wang, Yan Xia, Ping Lv, Quansheng Song, Dalong Ma, Yingyu Chen · 2017 · Cell Death and Disease